Stephen J. Nicholls

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial”.

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial

The Lancet Diabetes & Endocrinology(2023)10.1016/s2213-8587(23)00316-9

N/A

2.1DataRank · unranked

90 citations

Stephen J. Nicholls, Na Li, Michael J. Louie, Danielle M. Brennan, A. Michael Lincoff +2 more

Modernizing the Data Infrastructure for Clinical Research to Meet Evolving Demands for Evidence

JAMA(2024)10.1001/jama.2024.0268

N/A

0.940DataRank · unranked

25 citations

Caroline Marra, Atul Janardhan Butte, Laura Esserman, Lee A. Fleisher, Cynthia I. Grossman +64 more

The Integration of Clinical Trials With the Practice of Medicine

JAMA(2024)10.1001/jama.2024.4088

N/A

0.609DataRank · unranked

57 citations

Alison J. Huang, Roger J. Lewis, Amy P. Abernethy, Robert M. Califf, Martin Landray +63 more

Genome‐Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the CETP Gene

Journal of the American Heart Association(2023)10.1161/jaha.123.031459

N/A

0.533DataRank · unranked

18 citations

Andrew Bakshi, Gerald F. Watts, Alan E. Renton, Brian Fulton‐Howard, Alison Goate +12 more

Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristics

American Heart Journal(2025)10.1016/j.ahj.2025.07.012

N/A

0.522DataRank · unranked

9 citations

Christie M. Ballantyne, Ron Blankstein, Matthew J Budoff, Marc Ditmarsch, C. Michael Gibson +8 more

Polygenic risk, aspirin, and primary prevention of coronary artery disease

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae085

N/A

0.501DataRank · unranked

13 citations

Pradeep Natarajan, Aniruddh P. Patel, Harpreet Bhatia, Amit Khera, Franz–Josef Neumann +9 more

Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.06.045

N/A

0DataRank · unranked

91 citations

Stephen T. Vernon, Jason A. Harmer, Michael P. Gray, Clare Arnott, Eric Bachour +60 more

Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial

European Heart Journal(2024)10.1093/eurheartj/ehae614

N/A

0DataRank · unranked

26 citations

Danielle Duffy, M. Cecilia Bahit, Gerald Chi, Harvey D. White, Serge Korjian +71 more

Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.03.396

N/A

0DataRank · unranked

30 citations

Serge Korjian, M. Cecilia Bahit, Gerald Chi, Danielle Duffy, John H. Alexander +34 more

The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050

Journal of the American College of Cardiology(2025)10.1016/j.jacc.2025.04.061

N/A

0DataRank · unranked

38 citations

Jayanth Jayabaskaran, Silingga Metta Jauhari, Jobelle Chia, Carel W. le Roux, Anurag Mehta +28 more

Familial Hypercholesterolemia in a Healthy Elderly Population

Circulation Genomic and Precision Medicine(2020)10.1161/circgen.120.002938

N/A

0DataRank · unranked

9 citations

Robert Sebra, Moeen Riaz, Amanda J. Hooper, Jane Tiller, Andrew Bakshi +9 more

Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications

Thrombosis and Haemostasis(2025)10.1055/a-2674-5114

N/A

0DataRank · unranked

6 citations

Sina Rashedi, Gregory Y. H. Lip, C. Weber, Michelle L. O’Donoghue, Steven E. Nissen +8 more

Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study

European Heart Journal(2021)10.1093/eurheartj/ehab432

N/A

0DataRank · unranked

446 citations

Seth S. Martin, Erin D. Michos, Isha Lamba, Roger S. Blumenthal, Anum Saeed +10 more

Protective lipid-lowering genetic variants in healthy older individuals without coronary heart disease

medRxiv(2021)10.1101/2021.02.16.21251811

N/A

0DataRank · unranked

1 citations

Moeen Riaz, Robert Sebra, Amanda J. Hooper, Jing Pang, Jane Tiller +10 more

Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes

Journal of the American College of Cardiology(2022)10.1016/j.jacc.2022.07.027

N/A

0DataRank · unranked

142 citations

Andrew Bakshi, Moeen Riaz, Galina Polekhina, Alice Owen, Harpreet Bhatia +9 more